TBXU ETF

$32.66

Fund Essentials - as of Mar 31, 2026

Net Assets
$2M
Expense Ratio
0.98%
Dividend Yield (Current)
1.94%
Holdings
10
Inception Date
Oct 1, 2025
Fund Family
Direxion Shares ETF Trust
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Quarterly

Performance

YTD+6.43%

Asset Allocation

Stocks: 21.25%
Cash: 20.00%
Other: 58.75%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
-Dx D Biotech T 5 Bull 2X Etf Swap99.62%
-Dx D Biotech T 5 Bull 2X Etf Swap47.26%
DGCXXDreyfus Government Cash Management Fund, Institutional Shares19.61%
ARGX:NZArgenx Se - Adr11.03%
REGNRegeneron Pharmaceuticals11.01%
Top 10 Concentration: 224.94%Report Date: Mar 31, 2026
Download all 10 holdings for TBXU
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.94%
Frequency
Quarterly
Latest Distribution
$0.11
Jun 23, 2026
12M Distributions
4 payments
Total: $0.62

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

TBXU ETF Overview

TBXU ETF (Direxion Daily Biotech Top 5 Bull 2X ETF) is managed by Direxion Shares ETF Trust with $2.4M in net assets. TBXU expense ratio is 0.98%, holding 10 positions across sectors including Other, Health Care, Unknown. Inception date: 2025-10-01.

TBXU performance shows a YTD return of 6.43%.. TBXU dividend yield stands at 1.94%, paid quarterly.

TBXU top holdings include Dx D Biotech T 5 Bull 2X Etf Swap (99.6%), Dx D Biotech T 5 Bull 2X Etf Swap (47.3%), Dreyfus Government Cash Management Fund, Institutional Shares (19.6%), Argenx Se - Adr (11.0%), Regeneron Pharmaceuticals (11.0%). View all TBXU holdings, sector breakdown, or dividend history.

TBXU can be compared against other funds using the overlap calculator or side-by-side comparison tool. TBXU alternatives are available via the screener, along with tax-loss harvesting opportunities.

1 Month
+1.89%
YTD
+6.43%
1 Year
N/A
3 Year
N/A

Top 10 Holdings (net long exposure of 200% (≈2x))

#TickerNameSectorWeight
1-Dx D Biotech T 5 Bull 2X Etf SwapOther99.62%
2-Dx D Biotech T 5 Bull 2X Etf SwapOther47.26%
3DGCXXDreyfus Government Cash Management Fund, Institutional SharesFinancials19.61%
4ARGX:NZArgenx Se - AdrUnknown11.03%
5REGNRegeneron PharmaceuticalsUnknown11.01%
6AMGNAmgen Inc.Health Care10.44%
7VRTXNvaesrtex Pharmaceuticals IncHealth Care10.34%
8GILDGilead Sciences IncHealth Care10.30%
9FGTXXGoldman Finl Sq Trsry Inst 506Unknown5.33%